Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
China · Delayed Price · Currency is CNY 9.58
+0.05 (0.52%)
Sep 14, 2026, 11:29 AM CST
Shenzhen YHLO Biotech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 691.52 | 407.25 | 464.97 | 490.59 | 1,251 | 478.85 |
Short-Term Investments | - | 163.33 | 182.36 | 143.6 | 68.57 | - |
Trading Asset Securities | 14.15 | 116.23 | 69.59 | 76.66 | 114.16 | 16.15 |
Cash & Short-Term Investments | 705.67 | 686.81 | 716.93 | 710.85 | 1,433 | 495 |
Cash Growth | 3.86% | -4.20% | 0.85% | -50.40% | 189.56% | 113.03% |
Accounts Receivable | 613.3 | 596.1 | 523.85 | 414.19 | 346.38 | 254.43 |
Other Receivables | 39.75 | 43.93 | 54.23 | 48.11 | 66.2 | 21.48 |
Receivables | 653.05 | 640.03 | 578.08 | 462.3 | 412.58 | 275.91 |
Inventory | 617.2 | 601.97 | 670.77 | 634.5 | 569.54 | 363.81 |
Other Current Assets | 43.71 | 44.34 | 45.98 | 43.08 | 79.72 | 43.34 |
Total Current Assets | 2,020 | 1,973 | 2,012 | 1,851 | 2,495 | 1,178 |
Property, Plant & Equipment | 1,707 | 1,761 | 1,735 | 1,371 | 1,044 | 672.07 |
Long-Term Investments | 330.89 | 248.65 | 358.17 | 260.91 | 302.82 | 75.42 |
Goodwill | 5.29 | 5.29 | 5.29 | 5.29 | 5.29 | - |
Other Intangible Assets | 151.24 | 161.09 | 182.88 | 188.98 | 210.07 | 103.78 |
Long-Term Accounts Receivable | - | - | - | - | - | 3.76 |
Long-Term Deferred Tax Assets | 51.69 | 48.92 | 44.01 | 47.68 | 50.57 | 16.81 |
Long-Term Deferred Charges | 26.97 | 27.46 | 26.97 | 43.12 | 36.15 | 22.87 |
Other Long-Term Assets | 67 | 63.41 | 51 | 37.89 | 69.9 | 65.05 |
Total Assets | 4,360 | 4,289 | 4,415 | 3,806 | 4,214 | 2,138 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 190.71 | 142.97 | 213.13 | 203.81 | 307.76 | 137.6 |
Accrued Expenses | 88.26 | 132.85 | 164.42 | 145.99 | 211.11 | 54.88 |
Short-Term Debt | 376.37 | 279.48 | 292.32 | 171.07 | 279.36 | 150.82 |
Current Portion of Long-Term Debt | 32.15 | 27.51 | 23.8 | - | - | - |
Current Portion of Leases | 0.68 | 1.03 | 1.84 | 1.07 | 5.05 | 4.73 |
Current Income Taxes Payable | 0.36 | 18.3 | 4.59 | 13.27 | 75.73 | 12.27 |
Current Unearned Revenue | 134.55 | 149.26 | 184.5 | 183.51 | 528.61 | 111.09 |
Other Current Liabilities | 119.89 | 172.86 | 173.11 | 122.56 | 126.24 | 40.79 |
Total Current Liabilities | 942.95 | 924.27 | 1,058 | 841.28 | 1,534 | 512.17 |
Long-Term Debt | 576.9 | 587.83 | 585.44 | 381.89 | 183.9 | 73.26 |
Long-Term Leases | - | 0.07 | 2.39 | 3.57 | 5.24 | 4.89 |
Long-Term Unearned Revenue | 91.38 | 84.48 | 62.52 | 36.7 | 29.75 | 33.25 |
Long-Term Deferred Tax Liabilities | 2.05 | 2.47 | 4.54 | 9.06 | 15.88 | 0.02 |
Other Long-Term Liabilities | 3.27 | 2.28 | 0.74 | - | - | - |
Total Liabilities | 1,617 | 1,601 | 1,713 | 1,273 | 1,769 | 623.59 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 571.39 | 571.39 | 570.27 | 568.13 | 567 | 405 |
Additional Paid-In Capital | 518.88 | 518.59 | 480.36 | 432.24 | 389.51 | 525.03 |
Retained Earnings | 1,654 | 1,596 | 1,692 | 1,546 | 1,447 | 595.8 |
Comprehensive Income & Other | 7.83 | 11.7 | 14.38 | 13.53 | 13.84 | -0.12 |
Total Common Equity | 2,752 | 2,697 | 2,757 | 2,560 | 2,417 | 1,526 |
Minority Interest | -8.46 | -9.96 | -55.32 | -26.27 | 28.1 | -11.49 |
Shareholders' Equity | 2,743 | 2,687 | 2,702 | 2,534 | 2,445 | 1,514 |
Total Liabilities & Equity | 4,360 | 4,289 | 4,415 | 3,806 | 4,214 | 2,138 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 986.1 | 895.91 | 905.79 | 557.6 | 473.55 | 233.69 |
Net Cash (Debt) | -280.42 | -209.11 | -188.86 | 153.25 | 959.74 | 261.31 |
Net Cash Growth | - | - | - | -84.03% | 267.28% | - |
Net Cash Per Share | -0.46 | -0.36 | -0.33 | 0.27 | 1.69 | 0.48 |
Filing Date Shares Outstanding | 571.39 | 571.39 | 570.27 | 568.13 | 567 | 567 |
Total Common Shares Outstanding | 571.39 | 571.39 | 570.27 | 568.13 | 567 | 567 |
Working Capital | 1,077 | 1,049 | 954.06 | 1,009 | 961.27 | 665.88 |
Book Value Per Share | 4.82 | 4.72 | 4.83 | 4.51 | 4.26 | 2.69 |
Tangible Book Value | 2,595 | 2,531 | 2,569 | 2,366 | 2,202 | 1,422 |
Tangible Book Value Per Share | 4.54 | 4.43 | 4.50 | 4.16 | 3.88 | 2.51 |
Buildings | 1,052 | 1,054 | 891.92 | 342.69 | 322.37 | 222.47 |
Machinery | 1,706 | 1,635 | 1,370 | 1,069 | 817.66 | 582.7 |
Construction In Progress | - | - | 168.82 | 460.54 | 256.9 | 96.49 |